303 related articles for article (PubMed ID: 18577289)
41. Bilateral impairments of skilled reach-to-eat in early Parkinson's disease patients presenting with unilateral or asymmetrical symptoms.
Doan JB; Melvin KG; Whishaw IQ; Suchowersky O
Behav Brain Res; 2008 Dec; 194(2):207-13. PubMed ID: 18692094
[TBL] [Abstract][Full Text] [Related]
42. Levodopa-sensitive, dynamic changes in effective connectivity during simultaneous movements in Parkinson's disease.
Palmer SJ; Eigenraam L; Hoque T; McCaig RG; Troiano A; McKeown MJ
Neuroscience; 2009 Jan; 158(2):693-704. PubMed ID: 18722512
[TBL] [Abstract][Full Text] [Related]
43. Parkinson's disease.
Clarke C; Moore AP
Clin Evid; 2003 Dec; (10):1582-98. PubMed ID: 15555162
[No Abstract] [Full Text] [Related]
44. [Shifting to subcutaneous infusion of apomorphine in advanced Parkinson's disease patients on an out-patient basis: experience and recommendations].
Castaño B; Mateo D; Giménez-Roldán S
Neurologia; 2007 Apr; 22(3):133-7. PubMed ID: 17364250
[TBL] [Abstract][Full Text] [Related]
45. [Analysis of sustained attention in patients with Parkinson's disease being treated with dopamine precursors].
Luque-Moreno C; López-García JC; Díaz-Argandoña E
Rev Neurol; 2012 Sep; 55(5):257-62. PubMed ID: 22930136
[TBL] [Abstract][Full Text] [Related]
46. [Levodopa and cognitive disorders in Parkinson's disease].
Leiva-Santana C; Alvarez-Saúco M
Rev Neurol; 2006 Jul 16-31; 43(2):95-100. PubMed ID: 16838257
[TBL] [Abstract][Full Text] [Related]
47. Effects of internal clock and memory disorders on duration reproductions and duration productions in patients with Parkinson's disease.
Perbal S; Deweer B; Pillon B; Vidailhet M; Dubois B; Pouthas V
Brain Cogn; 2005 Jun; 58(1):35-48. PubMed ID: 15878725
[TBL] [Abstract][Full Text] [Related]
48. Recognition of category-related visual stimuli in Parkinson's disease: before and after pharmacological treatment.
Righi S; Viggiano MP; Paganini M; Ramat S; Marini P
Neuropsychologia; 2007 Oct; 45(13):2931-41. PubMed ID: 17662314
[TBL] [Abstract][Full Text] [Related]
49. The variability of levodopa response in Parkinson's disease: is sensitization reversible?
Jabre MG; Bejjani BP
Mov Disord; 2008 Apr; 23(6):924; author reply 925. PubMed ID: 18163452
[No Abstract] [Full Text] [Related]
50. Pharmacologic treatment of advanced Parkinson's disease: a meta-analysis of COMT inhibitors and MAO-B inhibitors.
Talati R; Reinhart K; Baker W; White CM; Coleman CI
Parkinsonism Relat Disord; 2009 Aug; 15(7):500-5. PubMed ID: 19167259
[TBL] [Abstract][Full Text] [Related]
51. Punding prevalence in Parkinson's disease.
Miyasaki JM; Al Hassan K; Lang AE; Voon V
Mov Disord; 2007 Jun; 22(8):1179-81. PubMed ID: 17230464
[TBL] [Abstract][Full Text] [Related]
52. Metamemory and prospective memory in Parkinson's disease.
Smith SJ; Souchay C; Moulin CJ
Neuropsychology; 2011 Nov; 25(6):734-40. PubMed ID: 21928905
[TBL] [Abstract][Full Text] [Related]
53. Reduction of the postexcitatory cortical inhibition upon paired-click auditory stimulation in patients with Parkinson's disease.
Lukhanina EP; Kapustina MT; Berezetskaya NM; Karaban IN
Clin Neurophysiol; 2009 Oct; 120(10):1852-8. PubMed ID: 19767236
[TBL] [Abstract][Full Text] [Related]
54. Parkinson's disease.
Clarke C; Moore AP
Clin Evid; 2004 Jun; (11):1736-54. PubMed ID: 15652077
[No Abstract] [Full Text] [Related]
55. Impact of recommendations on the initial therapy of Parkinson's disease: a population-based study in France.
Fayard C; Bonaventure A; Benatru I; Roze E; Dumurgier J; Moisan F; Soumaré A; Houssinot J; Dupupet JL; Mazurie JL; Balaboi I; Houeto JL; Krim E; Ranoux D; Goldberg M; Imbernon E; Moreau T; Giroud M; Tzourio C; Elbaz A
Parkinsonism Relat Disord; 2011 Aug; 17(7):543-6. PubMed ID: 21612970
[TBL] [Abstract][Full Text] [Related]
56. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.
Honig H; Antonini A; Martinez-Martin P; Forgacs I; Faye GC; Fox T; Fox K; Mancini F; Canesi M; Odin P; Chaudhuri KR
Mov Disord; 2009 Jul; 24(10):1468-74. PubMed ID: 19425079
[TBL] [Abstract][Full Text] [Related]
57. Pramipexole, ropinirole, and mania in Parkinson's disease.
Singh A; Althoff R; Martineau RJ; Jacobson J
Am J Psychiatry; 2005 Apr; 162(4):814-5. PubMed ID: 15800169
[No Abstract] [Full Text] [Related]
58. Levodopa "drug holiday" with amantadine infusions as a treatment of complications in Parkinson's disease.
Koziorowski D; Friedman A
Mov Disord; 2007 May; 22(7):1033-6. PubMed ID: 17370308
[TBL] [Abstract][Full Text] [Related]
59. Predictors of sudden onset of sleep in Parkinson's disease.
Körner Y; Meindorfner C; Möller JC; Stiasny-Kolster K; Haja D; Cassel W; Oertel WH; Krüger HP
Mov Disord; 2004 Nov; 19(11):1298-305. PubMed ID: 15389999
[TBL] [Abstract][Full Text] [Related]
60. [Parkinson's disease].
Jean-Luc H
Rev Prat; 2005 May; 55(10):1129-34. PubMed ID: 16097259
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
